Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMT vs GSK✓SelectedUSD · GSKAMT vs GSK performance historyLatest closeAs of-3.96%11/17
Stock and ETF performance explorer

AMT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+125.2%
GSK return
+104.0%
Excess return
+21.3%
Maximum drawdown
-45.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.0%-2.3%-1.6%-3.0%
7D-3.8%-3.0%-0.8%-2.5%
30D-1.1%+0.4%-1.5%-1.3%
3M+7.5%-1.2%+8.7%+7.8%
6M+9.6%+0.9%+8.6%+8.6%
YTD+7.5%+4.0%+3.5%+4.3%
1Y+5.6%+7.3%-1.7%+1.0%
3Y+3.0%+57.1%-54.1%-19.8%
5Y-16.3%+43.0%-59.3%-33.2%
10Y+125.2%+103.1%+22.2%+49.6%
All+125.2%+104.0%+21.3%+49.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling